NCT04520217View on ClinicalTrials.gov

Testing Use of Topical Imipramine in Reducing Ultraviolet B Induced Microvesicle Particle Release in Photosensitive Subjects

PHASE1RecruitingINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

June 6, 2022

Primary Completion Date

December 1, 2026

Study Completion Date

December 1, 2026

Conditions

PhotosensitivityMicrovesicle Particle

Interventions

DRUG

4% Imipramine Cream

4% Imipramine Cream

DRUG

Base Cream

Base Cream

Trial Locations (1)

45324

RECRUITING

Wright State Physicians, Fairborn

All Listed Sponsors

lead

Wright State University

OTHER